Anees Chagpar
Overview
Explore the profile of Anees Chagpar including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
42
Citations
397
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Trant A, Chagpar A, Wei W, Neumeister V, Rimm D, Stavris K, et al.
Integr Cancer Ther
. 2022 Nov;
21:15347354221137290.
PMID: 36444764
Background: Black cohosh (BC) () may prevent and treat breast cancer through anti-proliferative, pro-apoptotic, anti-estrogenic, and anti-inflammatory effects. This study sought to evaluate the effect of BC on tumor cellular...
2.
Foldi J, Kahn A, Silber A, Qing T, Reisenbichler E, Fischbach N, et al.
Clin Cancer Res
. 2022 Jul;
28(17):3720-3728.
PMID: 35903931
Purpose: The incidence of triple-negative breast cancer (TNBC) is higher among Black or African American (AA) women, yet they are underrepresented in clinical trials. To evaluate safety and efficacy of...
3.
Hwang E, Beitsch P, Blumencranz P, Carr D, Chagpar A, Clark L, et al.
JAMA Surg
. 2022 May;
157(7):573-580.
PMID: 35544130
Importance: Positive margins following breast-conserving surgery (BCS) are often identified on standard pathology evaluation. Intraoperative assessment of the lumpectomy cavity has the potential to reduce residual disease or reexcision rate...
4.
Dieli-Conwright C, Harrigan M, Cartmel B, Chagpar A, Bai Y, Li F, et al.
NPJ Breast Cancer
. 2022 Mar;
8(1):29.
PMID: 35256599
Few trials have examined the effect of lifestyle behavioral interventions on tissue markers in patients with cancer. The purpose of this study was to examine the feasibility and impact of...
5.
Foldi J, Silber A, Reisenbichler E, Singh K, Fischbach N, Persico J, et al.
NPJ Breast Cancer
. 2022 Feb;
8(1):17.
PMID: 35115541
No abstract available.
6.
Yazgan I, Chagpar A
Breast Cancer Res Treat
. 2022 Feb;
192(3):623-627.
PMID: 35107715
Background: Depression, anxiety, and other emotional disorders are highly prevalent; however, the impact of these on adherence to mammography screening guidelines remains unclear. We sought to determine the effect of...
7.
Saridakis A, Berger E, Harigopal M, Park T, Horowitz N, Le Blanc J, et al.
Ann Surg Oncol
. 2021 Aug;
28(10):5610-5616.
PMID: 34426884
Introduction: Invasive apocrine carcinoma is a rare breast cancer that is frequently triple negative. Little is known about the characteristics of its molecular subtypes. We compared the incidence, demographics, and...
8.
Sanft T, Harrigan M, Cartmel B, Ferrucci L, Li F, McGowan C, et al.
Contemp Clin Trials
. 2021 Jul;
109:106508.
PMID: 34274495
Background: The World Cancer Research Fund and the American Cancer Society provide nutrition and physical activity guidelines for cancer survivors. Many women with breast cancer do not follow these guidelines...
9.
Huang J, Wang M, Chagpar A
Am Surg
. 2021 Feb;
88(6):1386-1387.
PMID: 33565888
No abstract available.
10.
Foldi J, Silber A, Reisenbichler E, Singh K, Fischbach N, Persico J, et al.
NPJ Breast Cancer
. 2021 Feb;
7(1):9.
PMID: 33558513
The goal of this Phase I/II trial is to assess the safety and efficacy of administering durvalumab concurrent with weekly nab-paclitaxel and dose-dense doxorubicin/cyclophosphamide (ddAC) neoadjuvant therapy for stages I-III...